Article
Streamlining Inherited Cancer Identification via an EMR-Integrated Risk Assessment Platform: A Nonrandomized Clinical Trial.
JAMA network open - 1 Apr 2026
Orlando Lori A, Mittendorf Kathleen F, Bihlmeyer Nathan A, Bland Harris T, Myers Rachel A, Pratap Siddharth, Celaya-Cobbs Natasha, Andujar Justin, Gerhart Meredith, Sadeghpour Azita, Hooker Gillian, Wu R Ryanne, Marshall Dana R, Edwards Clasherrol, Frederickson Katie L, Leegon Jeff, Jones Sarah H, Rosenbloom S Trent, Peterson Josh F, Wiesner Georgia L
Abstract excerpt
Importance: Approximately 10% of cancers are attributable to heritable germline variants, yet identification of individuals at risk remains suboptimal. Objective: To assess the feasibility of personal history and family health history (FHH) risk assessment technology via the electronic medical record (EMR) to enhance identification of patients at risk for a broad array of inherited cancer syndromes. Design,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
